JPS6013719A - Coated solid rrug - Google Patents
Coated solid rrugInfo
- Publication number
- JPS6013719A JPS6013719A JP11954883A JP11954883A JPS6013719A JP S6013719 A JPS6013719 A JP S6013719A JP 11954883 A JP11954883 A JP 11954883A JP 11954883 A JP11954883 A JP 11954883A JP S6013719 A JPS6013719 A JP S6013719A
- Authority
- JP
- Japan
- Prior art keywords
- coated
- solid drug
- coating
- methyl cellulose
- viscosity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は改良された被覆固形薬剤C二関するものであり
、特には苦味のある固形薬剤を被覆いんぺいし、のみく
だすあいだ口内のだ液では溶解せず、胃中ではすみやか
に崩壊される被覆固形薬剤の提供を目的とする。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an improved coated solid drug C2, in particular a coated solid drug with a bitter taste, which does not dissolve in the saliva in the mouth and remains in the stomach while being swallowed. The purpose of the present invention is to provide a coated solid drug that is rapidly disintegrated.
従来、苦味のある固形薬剤のいんぺいには、特定pH溶
解型のアクリル系またはビニル系ポリマーを用いて被覆
することが行われている。すなわち、この被覆手段は口
内だ液(はぼ中性)では溶解せず、胃液(酸性)で溶解
する性質を利用したものであるうしかしながら、この従
来使用されている被覆剤はpH依存型の溶解特性をもつ
ものであるために胃中でのpH域がその被覆剤にとって
適当でない場合、たとえば無酸症患者などではその被覆
栗剤が背中で崩壊されずにそのまま通過してしまうとい
う間のがあった。Conventionally, solid drugs with a bitter taste have been coated with acrylic or vinyl polymers that are soluble at a specific pH. In other words, this coating takes advantage of the property that it does not dissolve in oral saliva (neutral) but dissolves in gastric juice (acidic).However, this conventionally used coating is pH-dependent. If the pH range in the stomach is not suitable for the coating because it has solubility properties, for example in patients with achlorhydria, the coating may pass through without being disintegrated on the back. was there.
一方、固形薬剤に使用される被覆剤として、ヒドロキシ
プロピルセルロース、ヒドロキシプロピルメチルセルロ
ースなどがあるが、これらの被覆剤は全pH領域溶解性
のものであるため、これを用いて被覆した薬剤は口内で
の溶解速度が早く、苦味のいんぺい効果が不十分である
。また溶解抑制時間を延長するために被覆膜の厚さを大
きくすると、効果は出るものの糊状を呈し、口内でのヌ
意研究した結果、メトキシ基置換量および水溶液粘度が
特定の範囲≦二あるメチルセルロースが本発明の目的に
きわめてすぐれた性能を発揮することを見出し、本発明
を完成した。On the other hand, coating materials used for solid drugs include hydroxypropyl cellulose and hydroxypropyl methylcellulose, but since these coating materials are soluble in all pH ranges, drugs coated with them are difficult to swallow in the mouth. The dissolution rate is fast, and the effect of bitterness is insufficient. Furthermore, if the thickness of the coating film is increased in order to extend the dissolution suppression time, although it is effective, it becomes pasty, and as a result of research on oral health, it was found that the amount of methoxy group substitution and the viscosity of the aqueous solution were within a specific range ≦2. The present invention was completed by discovering that a certain methylcellulose exhibits extremely excellent performance for the purpose of the present invention.
すなわち本発明は、固形薬剤を、メトキシ基含有倹24
〜33重惰%であり2%水溶液の20℃l二おける粘度
が3〜15センチボイズであるメチルセルロースで被覆
してなる被覆固形薬剤に関するものであり、これによれ
ば口内での苦味いんぺい効果にすぐれており、その際糊
化せずまたヌメリ感もほとんどなく、かつ胃中ではpH
値ζ二関係なく(無酸症患者であるとないとにかかわら
ずンすみやかに崩壊し、薬効を発揮するという利点が与
えられる。また本発明によれば被覆剤としてのメチルセ
ルロースが低粘度(低重合度]のものであるため、固形
薬剤の被覆(コーティング]が容易にしかも均一に行な
われるという利点も与えられる。That is, the present invention provides solid drugs with methoxy group-containing
This relates to a coated solid drug coated with methylcellulose, which has a concentration of ~33% by weight and a 2% aqueous solution having a viscosity of 3 to 15 cm at 20°C, and has an excellent effect of eliminating bitterness in the mouth. At that time, it does not gelatinize and has almost no slimy feeling, and the pH in the stomach is low.
Regardless of the value of degree of polymerization], it also has the advantage that solid drug coating can be easily and uniformly carried out.
本発明で対象とされる固形薬剤としては、細粒剤、顆粒
剤、丸剤、錠剤などであるが、特に苦味のあるものであ
り、被覆によってこの苦味をいんぺいするものである。The solid drugs targeted by the present invention include fine granules, granules, pills, tablets, etc., but they have a particularly bitter taste, and the bitter taste is counteracted by coating.
メチルセルロースはあらかじめ被覆液に調製され、被覆
工程に供されるのであるが、この被覆液調製は溶媒とし
て水あるいは水とアルコールとの混合溶媒、アルコール
と塩素化炭化水素との混合溶媒あるいはこれにさらに水
を加えたものなどを使用し、これにメチルセルロースを
おおむね2〜15重量%の濃度で溶解するという方法に
よればよい。なお、この被覆液には無機もしくは有機の
各稲光てん剤、可塑剤、着色剤、きよう味きょう奥側、
滑剤その他助剤を添加することは差支えない。Methyl cellulose is prepared in advance into a coating solution and subjected to the coating process, and the coating solution is prepared using water, a mixed solvent of water and alcohol, a mixed solvent of alcohol and chlorinated hydrocarbons, or even a mixed solvent of alcohol and chlorinated hydrocarbons. A method may be used in which methylcellulose is dissolved in a solution containing water at a concentration of approximately 2 to 15% by weight. In addition, this coating liquid contains inorganic or organic lightning strength agents, plasticizers, colorants, colorants,
There is no problem in adding lubricants and other auxiliary agents.
被覆操作は従来公知の方法たとえばパンコーティング法
、流動層コーティング法、通気回転ドラムコーティング
法などによればよく、スプレーガンよりメチルセルロー
スの被覆液を固形薬剤上ヘスプレーし乾燥することによ
りコーティング被膜が形成される。The coating operation may be performed by conventionally known methods such as pan coating, fluidized bed coating, aerated rotary drum coating, etc. A coating film is formed by spraying a methylcellulose coating solution onto the solid drug using a spray gun and drying it. Ru.
このようなコーティング操作により固形薬剤表面にコー
ティングされる皮膜量は固形薬剤の種類、形、大きさ、
さらにコーティングしようとする固形薬剤の表面状態な
どによって異なるが、その重量に対しておおむね2〜3
0%とすればよい。またこのコーティングを行った製剤
について従来公知の方法によりつや出し操作を施こして
もよい。The amount of film coated on the solid drug surface by such coating operation depends on the type, shape, size, and
Furthermore, it varies depending on the surface condition of the solid drug to be coated, but approximately 2 to 3
It may be set to 0%. Further, the coated preparation may be subjected to a polishing operation by a conventionally known method.
つぎに本発明の実施例を示す。Next, examples of the present invention will be shown.
実施例 1 (
(1)錠剤の作成
乳糖71重量部C以下単に部と記す)、臭化プロバンチ
リン(苦味成分)3部、とうもろこしデンプン18部、
低置換度ヒドロキシプロピルセルロース(LH−11:
信越化学社製商品名) 5部、ヒドロキシプロピルセル
ロース(Eya:信越化学社製商品名) 2部をV型混
合器にて20分間混合し、さらζニステアリン酸マグネ
シウム1部添加して2分間混合したものをロータリー打
錠機で直径9mm、1錠重量280ッの錠剤に成形した
。得られた錠剤は硬度約12 (ERWEKA)、崩壊
時間約8分33秒(日本薬局法第10改正法]であった
。Example 1 ((1) Preparation of tablets: 71 parts by weight of lactose (hereinafter referred to simply as parts), 3 parts of provantyline bromide (bitter component), 18 parts of corn starch,
Low substituted hydroxypropyl cellulose (LH-11:
5 parts of hydroxypropyl cellulose (Eya: trade name of Shin-Etsu Chemical Co., Ltd.) and 2 parts of hydroxypropyl cellulose (Eya: trade name of Shin-Etsu Chemical Co., Ltd.) were mixed for 20 minutes in a V-type mixer, and then 1 part of magnesium ζ-nistearate was added and mixed for 2 minutes. The mixture was formed into tablets with a diameter of 9 mm and a weight of 280 liters each using a rotary tablet press. The obtained tablet had a hardness of about 12 (ERWEKA) and a disintegration time of about 8 minutes and 33 seconds (Japanese Pharmaceutical Law, 10th Amendment).
(2)コーテイング液の調製
第1表1二示した被覆基剤6部を、エタノール75部と
水19部とからなる混合溶媒に溶解し、被覆液とした。(2) Preparation of coating liquid 6 parts of the coating base shown in Table 1 1-2 was dissolved in a mixed solvent consisting of 75 parts of ethanol and 19 parts of water to prepare a coating liquid.
(3)コーティング操作
上記(1)で作成した錠剤1即をフロイント産業性パン
コーティング装[FM−2に仕込み、これに(2)で調
製したコーテイング液を用いて次の条件でコーティング
した。(3) Coating operation One tablet prepared in the above (1) was placed in a Freund industrial pan coating machine [FM-2], and coated thereon with the coating solution prepared in (2) under the following conditions.
スプレー速度・・・・・・ 18d/分スプレー間隔・
・・・・・10秒スプレー15秒乾燥
錠剤温度・・・・・・・・・ 38〜40℃乾燥窄気温
度・・・・・・ 80℃
以上のようにしてコーティングした錠剤について諸試験
を行ったところ、結果は第1表に示Tとおりであった。Spray speed: 18d/min Spray interval:
...10 seconds spray 15 seconds drying Tablet temperature...38-40°C Drying air temperature...80°C Various tests were conducted on the coated tablets as above. The results were as shown in Table 1.
(イ)崩壊時間:日本薬局方第十改正崩壊試験法により
測定
(ロ)苦味いんぺい時間:コーティング錠剤2錠を口に
入れ、苦味を感じるまで
の時間を測定(パネラ−4人に
より行い平均した)。(a) Disintegration time: Measured according to the Japanese Pharmacopoeia 10th revised disintegration test method. (b) Bitter taste absorption time: Put two coated tablets in the mouth and measure the time until bitterness is felt (measured by a panel of 4 people and averaged). ).
()9ヌメリ感: (ロ)の苦味いんぺい時間測定時C
ニロ内におけるヌメリ感も併せ
調べた。()9 Slimy feeling: (B) When measuring bitterness time C
The sliminess inside Nilo was also investigated.
なお、fE1表中の略記号は下記の意味である。Note that the abbreviations in the fE1 table have the following meanings.
MC:メチルセルロース
HPMC:ヒドロキシプロビルメチルセルロースHPC
:ヒドロキシプロピルセルロース他方、対照例としてア
クリ)し共重合体(pH5以下で溶解するもの)を用い
、前記コーティング操作法(:準じて6%コーティング
した錠剤と第1表実験162の錠剤とを中性の水を試騨
液C二用いて崩壊試験を実施したところ、アクIJ )
し共重合体コニティングのものは全く崩壊しなかったの
C二対し、1ルのものは第1液を用いた場合と全く変わ
らないすみやかな崩壊性を示した。MC: Methylcellulose HPMC: Hydroxypropyl methylcellulose HPC
:Hydroxypropyl cellulose On the other hand, as a control example, a 6% coated tablet and the tablet of Experiment 162 in Table 1 were coated using the above coating method (:acrylic) and copolymer (which dissolves at pH 5 or less). When a disintegration test was carried out using liquid water with liquid C2, it was found that Aku IJ)
However, the copolymer coniting did not disintegrate at all, whereas the one with 1L showed a rapid disintegration property that was completely the same as when using the first liquid.
実施例2
(1)顆粒剤の作成
乳糖72.8部、臭化プロバンチリン1部、とうもろこ
しデンプン18.2部、低置換度ヒドロキシプロピルセ
ルロース(LH−11)5部、ヒドロキシプロピルセル
ロース(EF())3部をヘンシェルミキサーで30秒
間混合した後。Example 2 (1) Preparation of granules 72.8 parts of lactose, 1 part of provantyline bromide, 18.2 parts of corn starch, 5 parts of low-substituted hydroxypropylcellulose (LH-11), hydroxypropylcellulose (EF( )) After mixing 3 parts in a Henschel mixer for 30 seconds.
この混合米に対して水20部加えてさらに3分間線合し
た。この練合物を円筒型の製粒機で0、8 amのスク
リーンを用いて造粒し乾燥した。To this mixed rice, 20 parts of water was added and the rice was combined for an additional 3 minutes. This kneaded product was granulated in a cylindrical granulator using a 0.8 am screen and dried.
、Jtにより粒度16〜32メツシユ、摩損度(ロツシ
ュ型フライアビレータ−を用いて10分間操作後の48
メツシユバス率)0.5%、崩壊時間(日局10法)2
0秒の顆粒が得られた。, particle size 16-32 mesh depending on Jt, friability (48 after operating for 10 minutes using a Roche type fly ablator)
mesh bath rate) 0.5%, collapse time (Japanese station 10 method) 2
Granules of 0 seconds were obtained.
(2)コーテイング液の調製
第2表に示した被覆基剤5部を、エタノール75部と水
20部とからなる混合溶媒に溶解し、被覆液とした。(2) Preparation of coating liquid 5 parts of the coating base shown in Table 2 was dissolved in a mixed solvent consisting of 75 parts of ethanol and 20 parts of water to prepare a coating liquid.
(3)コーティング操作
上記(11で得た顆粒I Kgを大川原製作所製流動コ
ーティング装置GLATT We G −11−仕込み
、これに(2)で調製したコーテイング液を用いて次の
条件でコーティングした。(3) Coating operation I kg of the granules obtained in step 11 above were loaded into a fluid coating device GLATT We G-11 manufactured by Okawara Seisakusho, and coated with the coating solution prepared in step (2) under the following conditions.
スプレーガン・・・・・・ ノズル径0.8 txmス
プレー突気圧・・・・ 2.5Ky/cr/1スプレー
速度・・・・・・ 30・47分ダンパー・・・・・・
・入口5、川口2以上のよう(ニジてコーティングした
顆粒剤について諸試験を行ったところ、結果は第2表に
示すとおりであった。この結果から判るようl二本発明
の場合(二は口内におけるいんぺいが充分であり、一方
崩壊性がすぐれていて特(二問題となる溶出率にも全く
悪影響を及ぼさないことが認められた。Spray gun... Nozzle diameter 0.8 txm Spray gust pressure... 2.5 Ky/cr/1 spray speed... 30/47 minutes Damper...
・As shown in Inlet 5 and Kawaguchi 2 and above, various tests were conducted on the granules coated with water, and the results were as shown in Table 2.As can be seen from these results, in the case of the present invention (2 is It was found that the disintegration in the mouth was sufficient, and that the disintegration properties were excellent, and there was no adverse effect on the dissolution rate, which is a particular problem.
(イ)崩壊時間二日本薬局方第十改正崩壊試験法により
測定
(ロ)苦味いんぺい時間:コーティング顆粒約200キ
を口に入れ、苦味を感じ
るまでの時間を測定(パネラ−4
人により行い平均した)。(a) Disintegration time 2 Measured according to the Japanese Pharmacopoeia 10th revised disintegration test method (b) Bitter taste absorption time: Put approximately 200 kg of coated granules in the mouth and measure the time until bitterness is felt (measured by 4 panelists and averaged) did).
(/9ヌメリ感: (ロ)の苦味いんぺい時間測定時に
口内におけるヌメリ感も併せ調べ
た。(/9 Slimy feeling: When measuring the bitterness absorption time in (B), the slimy feeling in the mouth was also investigated.
(ニ)溶出試験:試験液には第1液(日局10法)を1
000−使用し、装置として
崩壊試験機を用いて行った。まず
試料2?を精秤し顆粒崩壊試験用
バスケットに入れて操作を行い、
10分毎にlO−をサンプリング
し、282mμの吸光度から溶出
率を測定した。なお、顆粒中の生
薬含有量は顆粒を乳鉢中ですりつ
ぶし第1液に分散させ、その吸光
度からめた。(d) Dissolution test: The test solution contains 1 part of the 1st solution (Japanese Pharmacopoeia method 10).
000-, and a disintegration tester was used as the apparatus. First, sample 2? The sample was precisely weighed and placed in a basket for granule disintegration test, and the operation was carried out. 1O- was sampled every 10 minutes, and the dissolution rate was measured from the absorbance at 282 mμ. The crude drug content in the granules was determined from the absorbance of the granules ground in a mortar and dispersed in the first liquid.
Claims (1)
あり2%水溶液の20℃g二おける粘度が3〜15セン
チボイズであるメチルセルロースで被覆してなる被覆固
形薬剤 2 前記固形薬剤が苦味のある細粒剤、顆粒剤、丸剤ま
たは錠剤である特許請求の範囲第1項記載の被覆固形薬
剤 3、 固形薬剤に対するメチルセルロース被覆量が2〜
30重量%である特許請求の範囲第1項記載の被覆固形
路側[Scope of Claims] 1. A coated solid drug obtained by coating a solid drug with methylcellulose having a methoxy group content of 24 to 33% by weight and a 2% aqueous solution having a viscosity of 3 to 15 centiboise at 20°C g2. The coated solid drug 3 according to claim 1, wherein the solid drug is a bitter-tasting fine granule, granule, pill, or tablet, wherein the amount of methylcellulose coated on the solid drug is 2 to 2.
The coated solid road side according to claim 1, which is 30% by weight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11954883A JPS6013719A (en) | 1983-07-01 | 1983-07-01 | Coated solid rrug |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11954883A JPS6013719A (en) | 1983-07-01 | 1983-07-01 | Coated solid rrug |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6013719A true JPS6013719A (en) | 1985-01-24 |
Family
ID=14764028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11954883A Pending JPS6013719A (en) | 1983-07-01 | 1983-07-01 | Coated solid rrug |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6013719A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63214296A (en) * | 1987-03-04 | 1988-09-06 | 株式会社東芝 | Washing machine |
US4874613A (en) * | 1987-03-06 | 1989-10-17 | Baker Cummins Pharmaceuticals, Inc. | Taste concealing pharmaceutical dosage unit |
JP2001192344A (en) * | 2000-01-11 | 2001-07-17 | Shin Etsu Chem Co Ltd | Film coatings and oral solid preparations |
EP1103253A3 (en) * | 1999-11-19 | 2001-08-01 | Shin-Etsu Chemical Co., Ltd. | Aqueous film coating agent and oral solid preparation |
KR20130049740A (en) | 2011-11-04 | 2013-05-14 | 신에쓰 가가꾸 고교 가부시끼가이샤 | Film coating composition and oral solid preparation |
EP3216807A1 (en) | 2016-03-09 | 2017-09-13 | Shin-Etsu Chemical Co., Ltd. | Coating composition containing methyl cellulose, method for producing the same, and solid preparation |
-
1983
- 1983-07-01 JP JP11954883A patent/JPS6013719A/en active Pending
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63214296A (en) * | 1987-03-04 | 1988-09-06 | 株式会社東芝 | Washing machine |
US4874613A (en) * | 1987-03-06 | 1989-10-17 | Baker Cummins Pharmaceuticals, Inc. | Taste concealing pharmaceutical dosage unit |
EP1103253A3 (en) * | 1999-11-19 | 2001-08-01 | Shin-Etsu Chemical Co., Ltd. | Aqueous film coating agent and oral solid preparation |
JP2001192344A (en) * | 2000-01-11 | 2001-07-17 | Shin Etsu Chem Co Ltd | Film coatings and oral solid preparations |
KR20130049740A (en) | 2011-11-04 | 2013-05-14 | 신에쓰 가가꾸 고교 가부시끼가이샤 | Film coating composition and oral solid preparation |
JP2013095730A (en) * | 2011-11-04 | 2013-05-20 | Shin-Etsu Chemical Co Ltd | Film coating composition and oral solid preparation |
EP3216807A1 (en) | 2016-03-09 | 2017-09-13 | Shin-Etsu Chemical Co., Ltd. | Coating composition containing methyl cellulose, method for producing the same, and solid preparation |
EP3216807B1 (en) | 2016-03-09 | 2018-06-20 | Shin-Etsu Chemical Co., Ltd. | Coating composition containing methyl cellulose, method for producing the same, and solid preparation |
US11021628B2 (en) | 2016-03-09 | 2021-06-01 | Shin-Etsu Chemical Co., Ltd. | Coating composition containing methyl cellulose, method for producing the same, and solid preparation |
EP3216807B2 (en) † | 2016-03-09 | 2022-05-18 | Shin-Etsu Chemical Co., Ltd. | Coating composition containing methyl cellulose, method for producing the same, and solid preparation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4749639B2 (en) | Process for producing coated granules with masked taste and immediate release of active ingredients | |
TWI228414B (en) | Pharmaceutical composition comprising carvedilol and hydrochlorothiazide, solid dosage form comprising it, and process for the production of the same | |
EP1753407A2 (en) | Sugar coatings and methods therefor | |
JPS6248618A (en) | Slow-releasing drug preparation and production thereof | |
CN105456223A (en) | Mesalazine sustained-release pellets, preparation method thereof and mesalazine sustained-release capsule | |
JPS6013719A (en) | Coated solid rrug | |
CA2634006C (en) | Pharmaceutical sustained release compositions comprising liothyronine or the sodium salt of liothyronine | |
JP2849047B2 (en) | Diclofenac sodium sustained-release preparation and its production method | |
HU191738B (en) | Process for producing retard compositions containing acetylsalicylic acid | |
CN101455653A (en) | Arginine ibuprofen oral disintegrating tablets and preparation method thereof | |
TWI286072B (en) | Sleeping medicine formed by coating solid | |
JP3034592B2 (en) | Oral solid preparation and production method thereof | |
JP3007387B2 (en) | Base powder for sustained release formulation | |
JPH03258730A (en) | Granule-containing tablet | |
JPH11335279A (en) | Ibuprofen-containing granules | |
CA2393614C (en) | Antibacterial clarithromycin compositions and processes for making the same | |
WO2011040195A1 (en) | Unpleasant taste-masking particles and an oral preparation containing same | |
JPH0774166B2 (en) | Method for producing sustained-release coated drug | |
JP4759905B2 (en) | Dragees | |
JP4864024B2 (en) | Timed release formulation | |
JP2001139495A (en) | Film coatings and oral solid preparations | |
JPH0774151B2 (en) | Process for producing powder which masks unpleasant organoleptic properties of drug | |
Sowmya et al. | Optimization and Analysis of Xanthan Gum and Hypromellose Combined Matrices for Extended Release of Ranolazine Using Quality by Design. | |
JP2005068116A (en) | Quick-release film-coated tablets containing metformin hydrochloride | |
CN109288836A (en) | A kind of dihydralazine sulfate,clonidine and hydrochlorothiazine preparation and its preparation method and application |